SEC Form 4 · accession 0001209191-18-003057
Juno Therapeutics, Inc. · JUNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard H Pien
Director
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 9:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001594864
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 22, 2017 | G | 25,000 | $0.00 | D | 129,633 | D | |
| Common StockF2 | Jan 5, 2018 | A | 417 | $0.00 | A | 130,050 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a bona fide gift of common stock; thus, there is no price associated with this transaction.
- F2Consists of fully vested restricted stock units.